Xianzi Yang

973 total citations
22 papers, 763 citations indexed

About

Xianzi Yang is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Xianzi Yang has authored 22 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Xianzi Yang's work include Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (7 papers) and Circular RNAs in diseases (7 papers). Xianzi Yang is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (7 papers) and Circular RNAs in diseases (7 papers). Xianzi Yang collaborates with scholars based in China and United States. Xianzi Yang's co-authors include Lisi Zeng, Shuzhong Cui, Qingjun He, Quanxing Liao, Ziying Lei, Zhen Tang, Tiantian Cheng, Jun Chi, Hong Zhang and Xing Wang and has published in prestigious journals such as PLoS ONE, Molecular Cancer and Cell Death and Disease.

In The Last Decade

Xianzi Yang

22 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xianzi Yang China 12 608 569 80 66 64 22 763
Yaliang Lan China 9 360 0.6× 296 0.5× 51 0.6× 45 0.7× 77 1.2× 12 526
Heng‐Chao Yu China 9 485 0.8× 395 0.7× 49 0.6× 45 0.7× 40 0.6× 13 622
Weihua Li China 16 450 0.7× 434 0.8× 57 0.7× 29 0.4× 93 1.5× 20 670
Sercan Ergün Türkiye 14 445 0.7× 413 0.7× 40 0.5× 33 0.5× 40 0.6× 43 643
Cuncun Yuan China 12 531 0.9× 407 0.7× 65 0.8× 39 0.6× 140 2.2× 18 664
Juan Jin China 10 377 0.6× 323 0.6× 54 0.7× 40 0.6× 52 0.8× 26 527
Jingping Ge China 18 546 0.9× 417 0.7× 43 0.5× 32 0.5× 71 1.1× 40 719
Tianwei Xu China 10 480 0.8× 399 0.7× 28 0.3× 55 0.8× 72 1.1× 16 597
Chengkun Qin China 16 336 0.6× 242 0.4× 80 1.0× 55 0.8× 174 2.7× 35 559

Countries citing papers authored by Xianzi Yang

Since Specialization
Citations

This map shows the geographic impact of Xianzi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianzi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianzi Yang more than expected).

Fields of papers citing papers by Xianzi Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianzi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianzi Yang. The network helps show where Xianzi Yang may publish in the future.

Co-authorship network of co-authors of Xianzi Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xianzi Yang. A scholar is included among the top collaborators of Xianzi Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianzi Yang. Xianzi Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lei, Ziying, Yue Wang, Jiali Luo, et al.. (2025). Hyperthermic intraperitoneal chemotherapy after upfront cytoreductive surgery for stage III epithelial ovarian cancer: Follow‐up of long‐term survival. Acta Obstetricia Et Gynecologica Scandinavica. 104(5). 988–997. 1 indexed citations
2.
Liu, Chang, Zheng Li, Yun‐Xin Lu, et al.. (2024). Paclitaxel hyperthermia suppresses gastric cancer migration through MiR-183-5p/PPP2CA/AKT/GSK3β/β-catenin axis. Journal of Cancer Research and Clinical Oncology. 150(9). 416–416. 1 indexed citations
3.
Li, Jinjie, Qin Lu, Chao Yang, et al.. (2023). Increased expression of LINC00323 correlates with tumor progression and poor prognosis of gastric cancer. Cancer Biomarkers. 38(3). 311–319. 2 indexed citations
4.
Yang, Xianzi, Lei Ma, Chuan Jin, et al.. (2022). Construction of a competing endogenous RNA network and identification of potential regulatory axes in gastric cancer chemoresistance. Pathology - Research and Practice. 234. 153904–153904. 4 indexed citations
5.
Jin, Chuan, Xianzi Yang, Feiyu Niu, et al.. (2022). A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinoma. Hepatology International. 16(5). 1220–1233. 5 indexed citations
6.
Zeng, Lisi, Quanxing Liao, Xianzi Yang, et al.. (2022). Noncoding RNAs and hyperthermic intraperitoneal chemotherapy in advanced gastric cancer. Bioengineered. 13(2). 2623–2638. 6 indexed citations
7.
Yang, Xianzi, et al.. (2021). High miR-3650 expression in nasopharyngeal carcinoma and its clinical prognostic values. Pathology - Research and Practice. 224. 153506–153506. 3 indexed citations
8.
Zeng, Lisi, Quanxing Liao, Xianzi Yang, et al.. (2021). Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids. Cancer Biology and Medicine. 18(3). 750–762. 20 indexed citations
9.
Yang, Xianzi, Ximin Chen, Lisi Zeng, et al.. (2020). Rab1A promotes cancer metastasis and radioresistance through activating GSK-3β/Wnt/β-catenin signaling in nasopharyngeal carcinoma. Aging. 12(20). 20380–20395. 13 indexed citations
10.
Zou, Zhaowei, Bin Liu, Lisi Zeng, et al.. (2019). Cx43 Inhibition Attenuates Sepsis-Induced Intestinal Injury via Downregulating ROS Transfer and the Activation of the JNK1/Sirt1/FoxO3a Signaling Pathway. Mediators of Inflammation. 2019. 1–13. 47 indexed citations
11.
Wang, Jiahong, Xianzi Yang, Yanxia Shi, et al.. (2019). Beneficial effects of Cripto-1 for transarterial chemoembolization in hepatocellular carcinoma. Aging. 11(10). 2998–3011. 4 indexed citations
12.
Zeng, Lisi, Quanxing Liao, Zhaowei Zou, et al.. (2018). Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway. Cellular Physiology and Biochemistry. 51(3). 1221–1236. 49 indexed citations
13.
Yang, Xianzi, Qingjun He, Tiantian Cheng, et al.. (2018). Predictive Value of LINC01133 for Unfavorable Prognosis was Impacted by Alcohol in Esophageal Squamous Cell Carcinoma. Cellular Physiology and Biochemistry. 48(1). 251–262. 20 indexed citations
14.
Yang, Xianzi, Tiantian Cheng, Qingjun He, et al.. (2018). LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway. Molecular Cancer. 17(1). 126–126. 310 indexed citations
15.
Wu, Xiaoliang, Zhongwen Li, Ling Gu, et al.. (2017). NORAD Expression Is Associated with Adverse Prognosis in Esophageal Squamous Cell Carcinoma. Oncology Research and Treatment. 40(6). 370–374. 40 indexed citations
16.
Chen, Min, Xiaoliang Wu, Wenjuan Ma, et al.. (2017). Decreased expression of lncRNA VPS9D1-AS1 in gastric cancer and its clinical significance. Cancer Biomarkers. 21(1). 23–28. 43 indexed citations
17.
Wen, Yue‐Feng, Xianzi Yang, Lisi Zeng, et al.. (2017). Prognostic impact of pretherapeutic gamma-glutamyltransferase on patients with nasopharyngeal carcinoma. PLoS ONE. 12(2). e0172345–e0172345. 8 indexed citations
18.
Wu, Xiaoliang, Xiao-Xiao Dinglin, Xing Wang, et al.. (2017). Long noncoding RNA XIST promotes malignancies of esophageal squamous cell carcinoma via regulation of miR-101/EZH2. Oncotarget. 8(44). 76015–76028. 64 indexed citations
19.
Wu, Xiaoliang, Ling Gu, Qi Shen, et al.. (2017). Long non-coding RNA ATB promotes malignancy of esophageal squamous cell carcinoma by regulating miR-200b/Kindlin-2 axis. Cell Death and Disease. 8(6). e2888–e2888. 70 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yaliang Lan Breakdown of academic impact, for papers by Heng‐Chao Yu Breakdown of academic impact, for papers by Weihua Li Breakdown of academic impact, for papers by Sercan Ergün Breakdown of academic impact, for papers by Cuncun Yuan Breakdown of academic impact, for papers by Juan Jin Breakdown of academic impact, for papers by Jingping Ge Breakdown of academic impact, for papers by Tianwei Xu Breakdown of academic impact, for papers by Chengkun Qin
Rankless by CCL
2026